Publication:
A middle-aged man with a troubled liver: Combination therapy in advanced (BCLC Stage C) hepatocellular carcinoma

Thumbnail Image

Files

A middle-aged man with a troubled liver Combination therapy in advanced (BCLC Stage C) hepatocellular carcinoma.pdf (757.43 KB)

Date

2017

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Sageya Publisher

Research Projects

Organizational Units

Journal Issue

Abstract

Advanced hepatocellular carcinoma carries a bad prognosis with a survival of only few months. Barcelona Clinic Liver Cancer (BCLC) Guidelines recommended sorafenib monotherapy as the treatment modality for advanced BCLC Stage C disease, citing a two-month increase in survival rates. Here, we highlight a case with advanced HCC (BCLC Stage C) treated with combination therapy of liver resection and Sorafenib therapy. The patient's current survival rate was beyond 10 months. We also discuss the current evidence on liver resection with Sorafenib therapy in hepatocellular carcinoma. The description of the case may benefit in future diagnosis and treatment.

Description

Volume 7, No 1

Keywords

Hepatocellular carcinoma, sorafenib, hepatectomy

Citation

URI

https://oarep.usim.edu.my/handle/123456789/6005

Collections

Other Publications